The CTS Rotea system aims to help researchers overcome manufacturing hurdles and bring the vast potential of cell therapies to more patients
Find out how experts at the Ellison Institute are harnessing new cell monitoring technology to build cancer cell biobanks and enhance cell line quality control and authentication
Partnership combines Twist’s leadership in DNA synthesis and synthetic biology with Neogene’s expertise in personalized engineered T cell therapies
Antibodies available are specific for S1, S2 and receptor-binding domain regions of SARS-CoV-2 Spike protein
Find out how to rapidly test for multiple disease-causing microorganisms with syndromic panel-based testing
EpiMOGRIFY supports the development of scalable off-the-shelf cell therapies for diseases with a high unmet clinical need
Combination test for COVID-19, flu and other common respiratory illnesses helps health care professionals prepare for flu season
The Phase II clinical trial, which will use cutting-edge CRISPR genetic engineering, has already begun enrolling patients
The addition of COVID-19 antibody tests to the portfolio aims to further support the pandemic response on multiple fronts
Join us Thursday, October 22, to explore the applications and benefits of ambient ionization for biomedical research and its future potential for pharma and food industries
Access SARS-CoV-2 IgG assay shows excellent agreement with the Genscript Surrogate Virus Neutralization Test
Fluidigm COVID-19 campus safeguard program improves availability of non-invasive, saliva-based SARS-CoV-2 tests for higher education institutions
Researchers have made a significant COVID-19 drug target discovery using Thermo Fisher Scientific CryoEM technology
We speak with Dr. Ed Emmott, founder of The Emmott Lab & COVID-19 Mass Spec Coalition member, about his latest research into the disease
Affimer-based research assay launched alongside performance data published by Bruker
Early surgical treatment of leg ulcers caused by varicose veins improves healing and reduces the risk of the condition coming back
CE mark for MitraClip G4 offers physicians an innovative next-generation system with more options for mitral valve repair using proven clip-based technology
Menu of test solutions for infectious diseases – which already includes COVID-19 – to be expanded, especially in the U.S.
The Direct assay is validated on a wide range of specimen types, and can be run in parallel with the Simplexa Flu A/B & RSV Direct Gen II assay
cPass is first commercially available product to rapidly detect neutralizing antibodies capable of eliminating virus
The new line aims to provide unmatched sensitivity, resolution, speed, and flexibility of colors
Emergency scans captured images of the top of the lungs where a fluffiness known as ‘ground glass opacification’ allowed COVID-19 to be diagnosed
AstraZeneca anticipates entering clinical development in 2021
The technology is said to be superior at identifying cell types in human blood, providing faster and more reliable assessments for clinical decision making
The new Elecsys Anti-SARS-CoV-2 S test can quantitatively measure the level of antibodies against SARS-CoV-2 in patients who have been exposed to the virus
